938 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
719 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
4,095 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
15,584 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
1,922 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
19,802 followers
RT @TaliLev123: #CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical tria…
1,869 followers
#CICON22: Keynote Address by @MackallLab about Expanding the reach of CAR T cell therapy for cancer. See this clinical trial published @CD_AACR about Mesothelin-Targeted CAR T + pembrolizumab therapy. https://t.co/z8v690Feu2 https://t.co/yLJiWvYecj
1,922 followers
RT @CD_AACR: An innovative trial for CAR T-cells in today's #AACR22 session! A phase I trial of regional #mesothelin-targeted CART cell the…
44 followers
RT @CD_AACR: An innovative trial for CAR T-cells in today's #AACR22 session! A phase I trial of regional #mesothelin-targeted CART cell the…
4,095 followers
RT @CD_AACR: An innovative trial for CAR T-cells in today's #AACR22 session! A phase I trial of regional #mesothelin-targeted CART cell the…
19,802 followers
An innovative trial for CAR T-cells in today's #AACR22 session! A phase I trial of regional #mesothelin-targeted CART cell therapy in patients with malignant pleural #mesothelioma, in combination with the anti-PD-1 agent pembrolizumab. https://t.co/Ub53fAP
19,802 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
1,099 followers
RT @CD_AACR: Check out this trial, A phase I trial of regional #mesothelin-targeted #CART cell therapy in patients with malignant pleural #…
1,869 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
4,095 followers
RT @CD_AACR: Check out this trial, A phase I trial of regional #mesothelin-targeted #CART cell therapy in patients with malignant pleural #…
19,802 followers
Check out this trial, A phase I trial of regional #mesothelin-targeted #CART cell therapy in patients with malignant pleural #mesothelioma, in combination with the anti-PD-1 agent pembrolizumab. https://t.co/6x3YRX7d7R @MSKCancerCenter #AACR22 #immunothera
4,904 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
6,931 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
963 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
104,290 followers
RT @ElizSMcKenna: Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-…
15,584 followers
Watching the #AACR22 session on CAR-T cells for solid tumors? ICYMI in @CD_AACR: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients w/ malignant pleural #mesothelioma, in combination with pembrolizumab @MSKCancerCenter https:/
5,982 followers
Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab https://t.co/bRwOsKEFNl
1,552 followers
RT @DrMiguelPerales: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
104,290 followers
RT @DrMiguelPerales: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
251 followers
RT @DrMiguelPerales: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
1,699 followers
RT @DrMiguelPerales: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
19,708 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab @sloan_kettering #ASH21 #BMTworkshop https://t.co/eTFy49Qokq
1,869 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
689 followers
RT @rahulshethmd: Congrats to the team @sloan_kettering on this exciting study! From an IR perspective, it’s the first (as far as I know) d…
260 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
1,255 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
1,069 followers
Congrats to the team @sloan_kettering on this exciting study! From an IR perspective, it’s the first (as far as I know) demonstration of the potential for local, catheter-based CAR-T delivery for solid tumors…very promising safety and efficacy data! @SIO_C
688 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
125 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
141 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
104,290 followers
RT @CD_AACR: From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleura…
19,802 followers
From the November issue: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothelioma, in combination with the anti-PD-1 agent pembrolizumab https://t.co/5JHzXvHRMG @sloan_kettering #immunotherapy ht
46 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab [Research Articles] https://t.co/vI4VG7acFE https://t.co/V8boRJ0lzH
1,111 followers
RT @ChristianRolfo: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combi…
907 followers
RT @ChristianRolfo: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combi…
468 followers
RT @MSKHemOncTrials: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
1,255 followers
RT @MSKHemOncTrials: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
1,067 followers
RT @ChristianRolfo: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combi…
15,584 followers
RT @MSKHemOncTrials: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Comb…
1,699 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab | #CARTcells #mesothelioma @sloan_kettering Cancer Discovery @CD_AACR https://t.co/wjg
15,584 followers
RT @ChristianRolfo: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combi…
6,434 followers
RT @ChristianRolfo: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combi…
6,244 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab @CD_AACR @curemeso @OncoAlert https://t.co/Gec5fGbg5p
959 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab https://t.co/Wwy70Qre95
1,662 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab https://t.co/Z6bvuA2PQY
688 followers
RT @VivekSubbiah: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combina…
15,584 followers
RT @VivekSubbiah: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combina…
39 followers
RT @StephenVLiu: Fantastic work by Dr. Prasad Adusumilli @CD_AACR on autologous mesothelin-targeted CAR-T therapy for mesothelioma. In comb…
1,277 followers
RT @VivekSubbiah: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combina…
134 followers
RT @VivekSubbiah: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combina…
2,229 followers
RT @VivekSubbiah: A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combina…
33,809 followers
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab https://t.co/WNmKcEPMoB
15,584 followers
RT @StephenVLiu: Fantastic work by Dr. Prasad Adusumilli @CD_AACR on autologous mesothelin-targeted CAR-T therapy for mesothelioma. In comb…
23,945 followers
2,650 followers
Phase 1 clinical trial using CAR T cells against #mesothelioma demonstrates safety & tolerability in 27 patients. Study also shows combination with PD-1 blockade enhances CAR T-cell function with a median OS of 1 yr. Further studies are still needed.
879 followers
New #immunotherapy work from researchers @sloan_kettering: A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab https://t.co/pOYv2ospYP
1,662 followers
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab https://t.co/T9pZVHq1jz
1,315 followers
RT @CD_AACR: #OnlineFirst: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothel…
1,869 followers
RT @CD_AACR: #OnlineFirst: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothel…
159 followers
RT @ElizSMcKenna: Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell thera…
408 followers
RT @ElizSMcKenna: Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell thera…
1,373 followers
RT @CD_AACR: #OnlineFirst: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothel…
15,584 followers
RT @CD_AACR: #OnlineFirst: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothel…
15,584 followers
RT @Emi_genetics: Super interesting work on MSLN and PD-1 in mesothelioma that should definitely be investigated in #PDAC we may have some…
160 followers
Super interesting work on MSLN and PD-1 in mesothelioma that should definitely be investigated in #PDAC we may have some interesting results on targeting specific PDAC subtypes coming in the future...
19,802 followers
#OnlineFirst: A phase I trial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural #mesothelioma, in combination with the anti-PD-1 agent pembrolizumab @sloan_kettering #immunotherapy https://t.co/zQ40bkfFGd https://t.co/E
114 followers
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab https://t.co/dqoLrfxpxO https://t.co/cAb5MZYpbu
6,244 followers
@curemeso
70 followers
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab https://t.co/U9gPvpbeAU https://t.co/7REiEPrhSh
1,272 followers
RT @ElizSMcKenna: Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell thera…
2,053 followers
RT @ElizSMcKenna: Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell thera…
14,106 followers
RT @ElizSMcKenna: Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell thera…
15,584 followers
Now in @CD_AACR - another #mesothelioma trial! A phase I #clinicaltrial of regional #mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab @sloan_kettering #immunotherapy ht